ISN 9.09% 6.0¢ isonea limited

20m in US alone asthma sufferers. 500m world wide. Let's say 1%...

  1. 10,843 Posts.
    lightbulb Created with Sketch. 4
    20m in US alone asthma sufferers. 500m world wide. Let's say 1% of the 20m buy a 50$ app from Isn. There is 10m revenue straight away. It looks simPle but all the foundation work has been laid with the wheezometer. Good times ahead here IMO. Remember $3300 is the average spend per patient per annum on asthma related costs. Bodes very well
 
watchlist Created with Sketch. Add ISN (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.